Back to company

2care4 Generics ApS: Financial statements 2024

CVR: 36960566

2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 58,190,000 and a net result of DKK 17,193,000 compared with DKK 31,564,000 the year before. That is a decrease of 20.7% compared with the year before. Equity amounted to DKK 78,737,000. The solvency ratio was 60.7%. The company had 20 employees in the financial year.

Gross Profit
58,190,000 kr.
Profit/Loss
17,193,000 kr.
Equity
78,737,000 kr.
Total Assets
129,738,000 kr.
Employees
20

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-58.2 mio.17.2 mio.78.7 mio.20
2023-73.4 mio.31.6 mio.86.5 mio.15
2022-75.7 mio.34.6 mio.74.2 mio.12
2021-55.9 mio.29.1 mio.44.6 mio.15
2020-32.9 mio.15.7 mio.15.5 mio.12

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 2care4 Generics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

2care4 Generics ApS: The 2023 annual report is outApr 30, 2024

2care4 Generics ApS has published its annual report for 2023. Gross profit came to DKK 73,414,000, and the net result was DKK 31,564,000.

Thomas Hjarsbæk Rasmussen joins 2care4 Generics ApS as directorApr 25, 2024

As of April 25, 2024, Thomas Hjarsbæk Rasmussen is registered as director of 2care4 Generics ApS.

About 2care4 Generics ApS

2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The company is owned by 2care4 Group ApS. The company has 7 employees. In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity amounted to DKK 49,944,000.